Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-076845
Filing Date
2025-04-09
Accepted
2025-04-09 16:12:16
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d938758ddefa14a.htm DEFA14A 32766
2 GRAPHIC g938758dsp002.jpg GRAPHIC 289665
3 GRAPHIC g938758dsp003.jpg GRAPHIC 244053
4 GRAPHIC g938758dsp004.jpg GRAPHIC 332400
5 GRAPHIC g938758dsp005.jpg GRAPHIC 399397
6 GRAPHIC g938758g0409213648861.jpg GRAPHIC 3838
  Complete submission text file 0001193125-25-076845.txt   1782100
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-16174 | Film No.: 25825339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)